CMS Calendar Year 2027 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Final Rule (CMS-1850-FC)
Overview
On November 4, 2026, CMS released the CY 2027 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Payment System (ASC) Final Rule (CMS–1850–FC), with the official Federal Register publication on November 6, 2026. This Rule and all policy updates will become effective on January 1, 2027.
Key Program Updates
OPPS and ASC Payment Rate Increase: CMS has finalized a 2.3% increase to OPPS payment rates for facilities meeting quality reporting requirements (based on a 3.2% market basket update minus a 0.9% productivity adjustment). Ambulatory Surgical Center payment rates are also set to increase by 2.3% for facilities meeting quality and reporting requirements.
CMS estimates that in addition to the finalized policy changes, these adjustments to the OPPS payments, utilization changes, and beneficiary cost-sharing will result in an estimated $9.5 million increase in payments from the prior year. The most impactful policy changes have been highlighted below.
Continued Elimination of the Inpatient-Only List: One of the most significant updates by CMS in the 2027 OPPS is the continued elimination of 637 of the remaining 1,400-plus services from the Medicare Inpatient-Only List, enabling their transition from the inpatient to the outpatient setting where appropriate. These services and their proposed status indicators and APC assignments are listed in the public use file titled “Proposed Procedures for Removal from the IPO List for CY 2027.”
The CY 2027 IPO updates span a wide variety of clinical families including (but not limited to): the auditory system, digestive system, endocrine system, female and male genital systems, hemic and lymphatic systems, maternity care and delivery, and the respiratory system.
CMS emphasized that services no longer included in the IPO list are payable in either the inpatient or hospital outpatient setting, subject to the long-standing two midnight rule and other coverage rules requiring that any procedure be reasonable and necessary, and payment should be made pursuant to the otherwise applicable payment policies. As such, the Agency reminds providers to use clinical judgment to decide whether a procedure should be performed (and billed) as an inpatient admission or an outpatient service.
It is further noteworthy that Dr. Mehmet Oz, Administrator of CMS, has reemphasized that although the Agency is still committed to the three-year strategy to wholly eliminate the long-standing IPO list, services and procedures that are removed from the list will remain immune from audit review until such time as the Agency determines otherwise. Furthermore, the Agency has explicitly deferred to the treating physician’s expert medical opinion as to whether their patient should be admitted or treated in an outpatient setting.
That said, it is strongly recommended that hospitals take steps now to perform an analytic deep dive to assess their current IPO composition, as well as the future potential revenue impact. Our team stands at the ready to assist in navigating this ongoing CMS strategy and is primed to offer tailored insight and recommendations.
Reduction in Payments for 340B-Acquired Drugs: Another major update in the CY 2027 OPPS is CMS’ shift to align Medicare payments with what hospitals actually pay to acquire drugs under the 340B Drug Pricing Program.
CMS took heed to substantial public commentary regarding the proposed adjustments and finalized this revision to the annual offset percentage for non-drug items and services from 0.5% to 2% effective CY 2027. CMS projects this 2% reduction will remain in effect until CY 2031, or when the estimated payment reduction reaches $7.8 billion.
A mandatory reporting element has also been finalized, with non-exempt 340B hospitals being required to report the “JG” billing modifier to identify if a drug was acquired under the 340B Program. Additionally, CMS finalized use of the “XX” modifier which will be required to be reported for all separately payable drugs that were purchased outside of the 340B Program. CMS commented that the required use of both modifiers will decrease the long-term administrative burden on hospitals by improving the completeness and consistency of claims data and reducing the need to resubmit incorrect claims.
Site-Neutral Payments: CMS is continuing its long-term strategic agenda to equalize payments between hospital-owned clinics and independent physician offices so that Medicare payments are not driven solely based on the care setting. For CY 2027, the primary target is imaging services that do not use contrast (such as standard X-rays, MRIs, or CT scans). When performed at excepted off-campus provider-based hospital departments (PBDs), these imaging services will be paid at the lower, standard Physician Fee Schedule (PFS) rate instead of the higher OPPS hospital rate.
CMS projects that this targeted imaging shift will save Medicare Part B roughly $260 million while reducing out-of-pocket copayments and premiums for beneficiaries. That said, to ensure compliance, CMS is introducing a mandatory provider-based attestation process whereby hospitals will be required to submit their initial documentation by December 31, 2027, or face complete payment denials beginning January 1, 2028.
Prior Authorization Expansion: CMS has also finalized the expansion of the use of prior authorization within the Medicare fee-for-service payment system for eight (8) additional botulinum toxin injection procedures. Citing a surge in the volume and utilization of these specific injection procedures during their routine data analysis as the rationale for this policy change, the goal of this expansion is to ensure the medical necessity for Medicare beneficiaries while protecting the Medicare Trust Fund from improper payments and unnecessary volume increases. CMS asserted they believe prior authorization is an effective mechanism to ensure Medicare beneficiaries receive medically necessary care while also protecting the Medicare Trust Fund. The effective date for the prior authorization for these procedures will begin with injections provided on or after July 1, 2027.
For more information regarding this Final Rule, CMS has developed a Fact Sheet for CY 2027 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Payment System (ASC) Final Rule (CMS–1850–F), highlighting the updates and offering additional insight into Agency intent.
Also On The Horizon for 2027:
The January 1, 2027, effective date of the CY 2027 CMS OPPS Final Rule is also the deadline for healthcare payers to fully implement four major Fast Healthcare Interoperability Resources (FHIR) application programming interfaces (APIs), pursuant to the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). While these compliance requirements primarily regulate payers, the shift directly impacts provider clinical workflows, electronic health record (EHR) utilization, and Medicare reimbursement.
The primary changes taking effect for providers by January 2027 include the following:
The End of Manual Prior Authorizations (ePA): Instead of dealing with portals, portals’ phone lines, or fax machines, your team can handle prior authorizations directly within your EHR.
New 2027 MIPS Attestation: To push providers toward adoption, CMS is tying the use of these APIs to provider revenue.
To capitalize on the January 2027 transition and ensure compliance, providers should prioritize three key actions:
- Audit EHR Capabilities: Connect with your EHR vendor to ensure they are upgrading your software to meet the 2015 Edition Cures Update or newer CEHRT criteria. Confirm that the HL7 FHIR Da Vinci Project implementation guides (such as CRD, DTR, and PAS) are being natively integrated for automated prior authorizations.
- Establish the Patient Attribution Roster: Payers are required to build “attribution processes” to know which patients belong to your practice. Work with your revenue cycle and billing teams to ensure your patient panels and NPI data are tightly synced with contracted payers, so your bulk data queries don’t get blocked.
- Update Staff Workflows: Retrain clinical and administrative staff to submit prior authorizations at the point of care via the EHR, rather than relying on historical manual habits like faxing or logging into separate payer portals.
*********
For information on additional work areas addressed in the Final Rule, refer to the following pages in the Final Rule:
- Blood Products Billing – page 29
- Comprehensive (C-APCs) – page 37
- OPPS Weighting – page 96
- Alaska and Hawaii Hospital Payment Adjustments – pages 105 and 920
- Non-Opioid Pain Treatment – page 1007
- Intra-Ocular Lenses – page 1024
- Quality Updates for ASC, Outpatient and Hospitals – page 1047